Journal of Gastrointestinal Oncology

Papers
(The TQCC of Journal of Gastrointestinal Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Clinicopathologic differences and mortality among Latinos and non-Latino whites with gastric cancer at a majority-minority cancer center in South Texas118
AKT inhibits the phosphorylation level of H2A at Tyr57 via CK2α to promote the progression of gastric cancer37
Rectal tumor fragmentation as a response pattern following chemoradiation25
Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-l25
Apparent diffusion coefficient is a good marker in predicting the prognosis in colorectal cancer liver metastases: a diagnostic study24
Does contrast-enhanced intraoperative ultrasound improve the sensitivity and predictive value of colorectal cancer liver metastasis detection?23
Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment i22
Correlation analysis of intestinal flora and immune function in patients with primary hepatocellular carcinoma22
Establishment of a prediction model of postoperative infection complications in patients with gastric cancer and its impact on prognosis22
Construction and validation of a prognostic nomogram for locally recurrent rectal cancer: a population-based study20
Gastric cancer complicated with hemophagocytic lymphohistiocytosis: case report and a brief review20
Survival in metastatic microsatellite-stable colorectal cancer correlated with tumor mutation burden and mutations identified by next-generation sequencing19
Effect of perioperative blood transfusion on complications and prognosis after radical gastrectomy in elderly patients: a retrospective study of 1,666 cases19
Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis18
The emerging role of intra-tumoral bacteria18
Hyperthermic intraperitoneal chemotherapy plus SOX chemotherapy versus SOX chemotherapy alone in patients with gastric cancer and peritoneal metastasis: a phase II randomized clinical trial18
MD2 blockage prevents the migration and invasion of hepatocellular carcinoma cells via inhibition of the EGFR signaling pathway18
Stage cT3 low rectal cancer: analysis of prognostic factors17
Low CPEB1 levels may predict the benefit of 5-fluorouracil treatment in patients with colon or stomach adenocarcinoma17
Identification of a pyroptosis-related gene prognostic signature in patients with hepatocellular carcinoma17
Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study16
Luteolin suppresses the growth of colon cancer cells by inhibiting the IL-6/STAT3 signaling pathway16
Efficacy and safety of radiotherapy combined with raltitrexed and irinotecan for treating unresectable recurrent colorectal cancer: a single-arm phase II trial16
Clinical and pathologic features correlated with rare favorable survival in patients with BRAFV600E mutated colorectal cancer16
Lymphadenectomy with venation is preferred compared to skeletonization for patients with rectal and sigmoid colon cancer: a retrospective cohort study16
Circular RNA ZFR promotes cell cycle arrest and apoptosis of colorectal cancer cells via the miR-147a/CACUL1 axis16
The role of biomarker in later-line treatment for metastatic colorectal cancer15
FAT10 promotes hepatocellular carcinoma (HCC) carcinogenesis by mediating P53 degradation and acts as a prognostic indicator of HCC15
Identification of gastric schwannoma and non-metastatic gastric stromal tumor by CT: a single-institution retrospective diagnostic test15
Impact on patient outcomes after regionalization of pancreatic surgery15
A new nomogram use neutrophil-to-lymphocyte ratio and fibrinogen-to-lymphocyte ratio to predict the recurrence of colorectal adenoma15
Knowledgeable case selection results in favorable outcomes15
An unusual paraesophageal and diaphragmatic SDHA-deficient gastrointestinal stromal tumor (GIST) metastases case report15
Nomogram for the prediction of lymph node metastasis and survival outcomes in rectal neuroendocrine tumour patients undergoing resection14
Total neoadjuvant therapy for locally advanced gastric cancer: too much of a good thing?14
Systematic review and meta-analysis of endoscopic ultrasonography in staging diagnosis of esophageal cancer after neoadjuvant radiotherapy and chemotherapy14
Efficacy and safety of low-dose apatinib plus S-1 versus regorafenib and fruquintinib for refractory metastatic colorectal cancer: a retrospective cohort study14
Prognosis of rectal neuroendocrine tumors after endoscopic resection: a single-center retrospective study14
Up-regulation of PUM1 by miR-218-5p promotes colorectal tumor-initiating cell properties and tumorigenesis by regulating the PI3K/AKT axis14
Ovarian transposition and metachronous ovarian metastasis in a premenopausal colorectal carcinoma patient: a case report14
Clinical analysis of tubular stapler-assisted nested anastomosis in the prevention of postoperative esophageal cancer complications14
Effects of recombinant human adenovirus type 5 combined with transarterial chemoembolization on postoperative metastasis and recurrence of hepatocellular carcinoma patients14
Molecular subtyping and IMScore based on immune-related pathways, oncogenic pathways, and DNA damage repair pathways for guiding immunotherapy in hepatocellular carcinoma patients14
A study of gene variation in All-RAS wild-type metastatic colorectal cancer and its correlation with cetuximab14
Identification of G-protein signaling modulator 2 as a diagnostic and prognostic biomarker of pancreatic adenocarcinoma: an exploration of its regulatory mechanisms13
Tumor mutation burden determined by a 645-cancer gene panel and compared with microsatellite instability and mismatch repair genes in colorectal cancer13
Value-based focused global population health management13
Lactic acid: a narrative review of a promoter of the liver cancer microenvironment13
Minimal residual disease monitoring via ctDNA: a case report of Lynch syndrome with synchronous colorectal cancer and review of literature12
ZIC5 promotes human hepatocellular carcinoma cell proliferation through upregulating COL1A112
Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of action of Wang Bu Liu Xing (Semen vaccariae) for colorectal cancer12
Clinical features and prognostic factors of patients with inoperable hepatocellular carcinoma treated with chemotherapy: a population-based study11
Intrathecal topotecan with systemic checkpoint inhibitor therapy for gastroesophageal cancer with leptomeningeal involvement: two case reports and review of the literature11
The prognostic value of the number of metastatic lymph nodes on the long-term survival of intrahepatic cholangiocarcinoma using the SEER database11
Patterns of regional lymph node metastasis predict postoperative overall survival and disease-free survival in locally advanced esophageal squamous cell carcinoma11
PD-1 inhibition combined with intensity-modulated radiotherapy, to better serve patients with retroperitoneal lymph node metastases from gastrointestinal cancer11
Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma11
Two families with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): case reports and literature review11
Prognostic role of myeloid-derived tumor-associated macrophages at the tumor invasive margin in gastric cancer with liver metastasis (GCLM): a single-center retrospective study11
Spontaneous regression of advanced hepatocellular carcinoma following COVID-19 infection and vaccination: a case report and review of literature11
ZNF326 as a potential prognostic and predictive biomarker in stage II colorectal cancer11
Efficacy of first-line chemotherapy based on primary site of tumor versus etoposide-platinum in advanced gastroenteropancreatic neuroendocrine carcinoma11
An unusual presentation of solitary ovarian metastasis from colorectal cancer in an elderly woman: a case report11
Identification of key modules and micro RNAs associated with colorectal cancer via a weighted gene co-expression network analysis and competing endogenous RNA network analysis11
Identification of a lactylation-related gene signature to characterize subtypes of hepatocellular carcinoma using bulk sequencing data11
Overall survival and treatment modalities in pancreatic adenocarcinoma: a retrospective analysis of a single centre in Western Australia11
Parkinson’s disease and the risk of gastrointestinal cancers: a two-sample Mendelian randomization study11
CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data10
Serum calcium improved systemic inflammation marker for predicting survival outcome in rectal cancer10
Diagnosis and treatment of postoperative bleeding in patients after gastrectomy: a retrospective case series study10
Development of a streamlined NGS-based TCGA classification scheme for gastric cancer and its implications for personalized therapy10
Metastasis patterns and prognosis in patients with gastric cancer: a Surveillance, Epidemiology, and End Results-based analysis10
Profiles of immune infiltration in the tumor microenvironment of hepatocellular carcinoma10
Retrospective study of combined pelvic exenteration in the treatment of primary and recurrent pelvic malignant tumors10
The clinical efficacy and safety of 3D vascular reconstruction combined with 3D navigation in laparoscopic hepatectomy10
A discussion of the gut microbiome’s development, determinants, and dysbiosis in cancers of the esophagus and stomach10
Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients10
Short-term clinical effects of robot-assisted esophagectomy with thoracic duct resection10
Hepatoid adenocarcinoma of the stomach: discrimination from conventional gastric adenocarcinoma with a computed tomography-based radiomics nomogram10
Nomogram-based prognostic stratification for patients with large hepatocellular carcinoma: a population study of SEER database and a Chinese cohort10
Development of a prognostic score for recommended transarterial chemoembolization candidates with spontaneous rupture of hepatocellular carcinoma10
MiR-448 suppresses cell proliferation and glycolysis of hepatocellular carcinoma through inhibiting IGF-1R expression10
Disulfidptosis-related genes of prognostic signature and immune infiltration features in hepatocellular carcinoma supported by bulk and single-cell RNA sequencing data10
The feasibility and safety of the brachial artery approach in the treatment of hepatic artery infusion chemotherapy: a retrospective study10
Anatomical observation and clinical significance of the left gastric vein in laparoscopic radical gastrectomy10
Overall survival and toxicity of hepatocellular carcinoma Barcelona Clinic Liver Cancer B patients receiving Y90 radioembolization: analysis of the radiation-emitting SIR-spheres in non-resectable liv10
The evolving treatment paradigm of locally advanced rectal cancer: a narrative review10
Evaluating the mitochondrial structure and gene expression profile of regenerated liver tissues in mice after 85% partial hepatectomy10
Risk factors of lymph node metastasis in patients with T1 stage colorectal cancer—a retrospective cohort study based on the Surveillance, Epidemiology, and End Results database10
Nasal alar metastasis of advanced hepatocellular carcinoma misdiagnosed as reactive cutaneous capillary endothelial proliferation in a patient treated with camrelizumab and apatinib: a case report10
The role of adjuvant chemotherapy after neoadjuvant chemotherapy or chemoradiotherapy plus esophagectomy in patients with esophageal cancer: a retrospective cohort study10
Management and mechanism of calciphylaxis in a patient treated with the FGFR inhibitor pemigatinib—a case report10
Adaptive immunity profiling associated with histological subtypes and postoperative survival in gastric cancer9
Effect of ramucirumab plus paclitaxel in advanced gastric cancer according to the status of programmed cell death-ligand 1 (PD-L1) expression9
miR-744-5p suppresses tumor proliferation and metastasis by targeting transforming growth factor-beta 1 (TGF-β1) in hepatocellular carcinoma (HCC)9
A post-marketing safety study of ramucirumab with FOLFIRI in patients with metastatic colorectal cancer9
Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration9
Structured training curricula for robotic colorectal surgery in China: does laparoscopic experience affect training effects?9
ACTB may serve as a predictive marker for the efficacy of lenvatinib in patients with HBV-related early-stage hepatocellular carcinoma following partial hepatectomy: a retrospective cohort study9
Efficacy and safety of camrelizumab plus chemotherapy versus chemotherapy alone in patients with untreated, HER2-negative, unresectable locally advanced, or metastatic gastric cancer or gastroesophage9
Risk factors for sepsis in patients with colorectal cancer complicated with gastrointestinal perforation and its impact on prognosis9
Helicobacter pylori-induced protein tyrosine phosphatase receptor type C as a prognostic biomarker for gastric cancer9
Gelatin sponge microparticles for transarterial chemoembolization combined with regorafenib in hepatocellular carcinoma: a single-center retrospective study9
Survival outcomes of neoadjuvant and adjuvant chemoradiotherapy for locally advanced adenocarcinoma of the oesophagogastric junction: a retrospective cohort study using the SEER database9
Optimal adjuvant chemotherapy completion time for stage III colon cancer: a cohort study9
The landscape of PD-L1 expression and somatic mutations in hepatocellular carcinoma9
Colorectal cancer in adolescent and young adults: epidemiology in Japan and narrative review8
Erratum to Colon cancer-associated transcript-1 enhances glucose metabolism and colon cancer cell activity in a high-glucose environment in vitro and in vivo8
Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in elderly patients with gastric cancer after surgery8
Screening of a novel autophagy-related prognostic signature and therapeutic targets in hepatocellular carcinoma8
Conservative treatment of hepatic portal vein gas after transarterial chemoembolization treatment for liver metastasis of postoperative esophageal cancer: a case report8
Identification of acetylshikonin as a novel tubulin polymerization inhibitor with antitumor activity in human hepatocellular carcinoma cells8
Cadherin dysregulation in gastric cancer: insights into gene expression, pathways, and prognosis8
New insights in the pathology of peritoneal surface malignancy8
Artemisinin inhibits the development of esophageal cancer by targeting HIF-1α to reduce glycolysis levels8
Transforming hyperthermic intraperitoneal chemotherapy: using computer simulation to improve HIPEC treatments8
Assessing the value of computed tomography (CT) of the chest in the follow-up of patients with intrahepatic cholangiocarcinoma8
A HER2-mutant patient with late-stage duodenal adenocarcinoma benefited from anti-HER2 therapy and PD-1 inhibition: a case report8
High expression of RBM15 is associated with better prognosis in esophageal squamous cell carcinoma8
Pattern of distant metastases and predictive nomograms in colorectal mucinous adenocarcinoma: a SEER analysis8
Esophageal cancer stem cells reduce hypoxia-induced apoptosis by inhibiting the GRP78-perk-eIF2α-ATF4-CHOP pathway in vitro8
Analysis of dynamic molecular networks: the progression from colorectal adenoma to cancer8
Camrelizumab and apatinib combined with chemotherapy in perioperative effective therapy for advanced gastric carcinoma with peritoneal metastasis: a case report8
The stress hyperglycemia ratio, a novel index of relative hyperglycemia, predicts short-term mortality in critically ill patients after esophagectomy8
Cancer metastasis to the upper gastrointestinal tract—a case series8
Bee venom protects against pancreatic cancer via inducing cell cycle arrest and apoptosis with suppression of cell migration8
The development and validation of pathological sections based U-Net deep learning segmentation model for the detection of esophageal mucosa and squamous cell neoplasm8
Current management of gastric adenocarcinoma: a narrative review8
Effects of YAP1 and SFRP2 overexpression on the biological behavior of colorectal cancer cells and their molecular mechanisms8
Construction and evaluation of prognostic models for esophageal cancer patients with distant and non-distant metastases: providing a reference process for clinical diagnosis and treatment8
Factors associated with the refusal of surgery and the associated impact on survival in patients with rectal cancer using the National Cancer Database8
Utility and specificity of plasma heat shock protein 90 alpha, CEA, and CA199 as the diagnostic test in colorectal cancer liver metastasis7
The efficacy and safety of gemcitabine-based combination therapy vs. gemcitabine alone for the treatment of advanced pancreatic cancer: a systematic review and meta-analysis7
Comparison of the safety and prognosis of sequential regorafenib after sorafenib and lenvatinib treatment failure in patients with unresectable hepatocellular carcinoma: a retrospective cohort study7
A more radical perspective on surgical approach and outcomes in pancreatic cancer—a narrative review7
Medullary carcinoma of the duodenum treated with pembrolizumab: a case report7
Development and verification of a microsatellite instability-related risk signature for predicting survival and therapy effectiveness in gastric cancer7
REXO4 acts as a biomarker and promotes hepatocellular carcinoma progression7
Prognostic value and clinicopathological correlation of the tumor regression grade in neoadjuvant chemotherapy for gastric adenocarcinoma: a retrospective cohort study7
Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancer7
Correlation analysis of tumor mutation burden of hepatocellular carcinoma based on data mining7
Clinical application of nano-carbon to improve the accuracy of lymph node staging in patients with advanced gastric cancer receiving neoadjuvant chemotherapy: a prospective randomized controlled trial7
Effect of negative emotions on patients with advanced gastric cancer receiving systemic chemotherapy: a prospective study7
Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma7
Abrogation of ARF6 in promoting erastin-induced ferroptosis and mitigating capecitabine resistance in gastric cancer cells7
Narrative review of the role of yttrium-90 selective internal radiation therapy in the surgical management of colorectal liver metastases7
AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma7
TiaochangXiaoliu decoction inhibits azomethane (AOM)/dextran sulfate sodium (DSS)-induced colorectal cancer by regulating immune response7
Hyperthermic intraperitoneal chemotherapy in prevention of gastric cancer metachronous peritoneal metastases: a systematic review7
Two-finger digital rectal examination for the diagnosis of anal fistula: protocol for a randomized controlled trial7
Effects of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione on autophagy and the PI3K/AKT/mTOR signaling pathway in human cholangiocarcinoma QBC939 cells7
Intraperitoneal gemcitabine chemotherapy is safe for patients with resected pancreatic cancer: final clinical and pharmacologic data from a phase II protocol and recommended future directions7
Interleukin 13 participates in terminal differentiation of esophageal squamous cell carcinoma cells7
Development and validation of a dual-energy CT-based model to estimate the malignant probability of distal gastric wall thickening7
Prognosis of patients with esophageal squamous cell carcinoma undergoing surgery versus no surgery after neoadjuvant chemoradiotherapy: a retrospective cohort study7
A novel biomarker NIFK-AS1 promotes hepatocellular carcinoma cell cycle progression through interaction with SRSF107
A novel risk stratification for predicting prognosis of colorectal cancer patients with bone metastasis7
ACTR3 promotes cell migration and invasion by inducing epithelial mesenchymal transition in pancreatic ductal adenocarcinoma7
The role of oral health in gastrointestinal malignancies6
Imatinib-associated skin rash is related to treatment outcome in patients with unresectable and/or metastatic gastrointestinal stromal tumor6
Biliary cancer brain metastases: a multi-institution case series with case reports6
Comparison of efficacy and safety between endoscopic and laparoscopic resections in the treatment of gastric stromal tumors: a systematic review and meta-analysis6
A retrospective cohort study on the efficacy and safety for combination therapy of immunotherapy, targeted agent, and chemotherapy versus immunochemotherapy or chemotherapy alone in the first-line tre6
Antidiabetic treatment improves prognosis after radical resection in hepatocellular carcinoma patients with diabetes mellitus: a retrospective cohort study from 2000 to 20136
Survival outcome and prognostic factors of remnant gastric cancer: a propensity score-matched analysis6
Surgical microwave ablation for multifocal non-resectable liver metastases: a single institution experience treating five or more liver lesions6
Immunotherapy before liver transplant in unresectable hepatocellular carcinoma: a case report6
Atypical pattern of response in rectal cancer after neoadjuvant pembrolizumab treatment: a case report, literature review, and proposed management model6
Long non-coding RNA CNALPTC1 promotes gastric cancer progression by regulating the miR-6788-5p/PAK1 pathway6
Chemoprotective effect of boeravinone B against 1,2-dimethyl hydrazine induced colorectal cancer in rats via suppression of oxidative stress and inflammatory reaction6
Correlation of ulcerative colitis and colorectal cancer: a systematic review and meta-analysis6
High albumin-bilirubin grade predicts worse short-term complications in gastric cancer patients with metabolic syndrome: a retrospective study6
Erratum to Construction and validation of a predictive model for the risk of three-month-postoperative malnutrition in patients with gastric cancer: a retrospective case-control study6
Perineural invasion is a prognostic factor in stage II colorectal cancer but not a treatment indicator for traditional chemotherapy: a retrospective cohort study6
Co-amplification of genes in chromosome 8q24: a robust prognostic marker in hepatocellular carcinoma6
Identification of lncRNAs based on different patterns of immune infiltration in gastric cancer6
Outcomes in octogenarians following elective colorectal cancer surgery6
Interfering HMGB3 release from cancer-associated fibroblasts by miR-200b represses chemoresistance and epithelial-mesenchymal transition of gastric cancer cells6
B7-H3 enhances colorectal cancer progression by regulating HB-EGF via HIF-1α6
Patterns-of-care disparities among uninsured versus insured patients with anorectal carcinoma referred for radiotherapy at an Urban Safety-Net Hospital6
The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review6
A narrative review of imaging for pancreas adenocarcinoma: staging, surgical considerations, and surveillance6
Comprehensive analysis of immune related lncRNAs in the tumor microenvironment of stage II–III colorectal cancer6
Collagen XV mediated the epithelial-mesenchymal transition to inhibit hepatocellular carcinoma metastasis6
Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer6
A narrative review of intraoperative use of indocyanine green fluorescence imaging in gastrointestinal cancer: situation and future directions6
Colorectal cancer surgery in elderly patients 80 years and older: a comparison with younger age groups6
Prospective comparison of positron emission tomography (PET)/magnetic resonance and PET/computed tomography dosimetry in hepatic malignant neoplastic disease after 90Y radioembolization treatment6
Determining the optimal number of examined lymph nodes for prognosis in colon cancer: a population-based study stratified by tumor location and T stage6
Transjugular intrahepatic portosystemic shunt for the management of symptomatic malignant pseudocirrhosis6
A systematic review and meta-analysis on the efficacy of Compound Kushen Injection in 3 kinds of digestive tract tumor6
miR-133a-5p suppresses gastric cancer through TCF4 down-regulation6
Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection6
Metabolomics for early pancreatic cancer detection in plasma samples from a Swedish prospective population-based biobank6
Epidemiology, survival and new treatment modalities for intrahepatic cholangiocarcinoma6
The clinical potential of circulating immune cell counts in primary gastric lymphoma6
Favorable tumor biology in locally advanced pancreatic cancer—beyond CA19-96
Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more6
Was ulcerative colitis one of the risk factors of colorectal cancer?6
Value-based chronic care model approach for vulnerable older patients with multiple chronic conditions6
Pembrolizumab combined with paclitaxel and platinum as induction therapy for locally advanced esophageal squamous cell carcinoma: a retrospective, single-center, three-arm study6
Camrelizumab combined with apatinib for unresectable, metastatic esophageal squamous cell carcinoma: a single-center, single-arm, prospective study6
Prognostic nomogram in patients with gastrointestinal stromal tumors: a SEER-based study6
Artificial intelligence algorithm was used to establish and verify the prediction model of portal hypertension in hepatocellular carcinoma based on clinical parameters and imaging features6
Inhibition of GABAergic neurons in the paraventricular nucleus of the hypothalamus precipitates visceral pain induced by pancreatic cancer in mice6
Association between the frequency of tooth brushing and esophageal carcinoma risk: an update systematic review and meta-analysis5
Prediction of early recurrence in patients with colorectal liver metastases5
ANTXR1 as a potential prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma identified by a weighted gene correlation network analysis5
Risk factors and efficacy outcomes of early-onset severe neutropenia due to paclitaxel or nanoparticle albumin-bound paclitaxel combined with ramucirumab in advanced gastric cancer: a multicenter retr5
Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: a retrospective cohort study5
Liver transplantation for cholangiocarcinoma: exploring a new land5
Massive pancreatic serous cystadenomas raise important questions regarding surgical management of incidental pancreatic cystic lesions: a report of two cases5
Treatment paradigms and survival outcomes in esophageal adenocarcinoma with liver metastasis: a retrospective cohort study using the SEER database5
Association between progression-free survival and metal stent patency in patients with advanced pancreatic cancer5
Single institution best recommendation is HIPEC with cisplatin and docetaxel5
Congenital cardiac liver cirrhosis with combined hepatocellular-cholangiocarcinoma—a case report5
Conversion resection of initially unresectable hepatocellular carcinoma associated with steatohepatitis through hepatic artery infusion chemotherapy-transarterial chemoembolization and systemic therap5
Validation of a genotype-based algorithm that identifies individuals with low, intermediate, and high serum CA19-9 levels in cancer-free individuals and in patients with colorectal cancer5
Construction and validation of a nomogram model for predicting peritoneal metastasis in gastric cancer based on ferroptosis-relate genes and clinicopathological features5
In vitro study of miRNA-369-3p targeting TCF4 regulating the malignant biological behavior of colon cancer cells5
Hepatoid esophagogastric adenocarcinoma and tumoral heterogeneity: a case report5
Association of sleep duration, sleep apnea, and shift work with risk of colorectal neoplasms: a systematic review and meta-analysis5
Endoluminal tumor implant of a colorectal cancer in an anal fistula detected by FISH techniques: a case report5
Comparison of delta-shaped anastomosis and Billroth I reconstruction after laparoscopic distal gastrectomy for gastric cancer5
A novel robust nomogram based on preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) for predicting lymph node metastasis of gastric cancer5
LINC00178 promotes cell growth, migration, and invasion in colorectal cancer in vitro and in vivo5
Efficacy and tolerability of the combination of nano-liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma: post-approval clinic experience5
Prediction and validation of circulating G-quadruplexes as a novel biomarker in colorectal cancer5
A case of nivolumab-induced cervical lymphadenopathy in a patient with gastric cancer5
Red cell distribution width—a potential prognostic indicator for colorectal cancer patients after radical resection in China5
Aggressive local treatments may prolong survival but do not have curative intent5
Peritoneal progression after pancreaticoduodenectomy is a devastating surgical treatment failure: HIPEC gemcitabine is an option5
The role of TMSB15A in gastric cancer progression and its prognostic significance5
Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic adenocarcinoma: a pilot study of the clinical trial EudraCT 2016-004298-415
New onset diabetes predicts clinical outcomes in patients with pancreatic adenocarcinoma5
Hyperthermic intra-operative intraperitoneal chemotherapy as an adjuvant to pancreatic cancer resection5
Establishment and verification of a prognostic tumor microenvironment-based and immune-related gene signature in colon cancer5
Efficacy and safety of transarterial chemoembolization-lenvatinib sequential therapy for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study5
Development and validation of a predictive scoring system for post-transarterial chemoembolization pain management in liver cancer patients5
Study on safety and efficacy of regorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma after first-line targeted therapy5
Systemic therapy in addition to cytoreduction and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: recent insights from clinical studies and translational research5
A randomized controlled trial of positive end-expiratory pressure on pulmonary oxygenation and biventricular function in esophageal cancer patients receiving one-lung ventilation under a lower FiO25
Response to anti-EGFR therapy in chemo-refractory right-sided RAS wild-type metastatic colorectal cancer: a case report and literature review5
Transcecum catheterization ileostomy is safe and effective to prevent anastomotic leakage in post-laparoscopic rectal cancer surgery: a single-center retrospective study5
The predictive value of RNA binding proteins in colon adenocarcinoma5
Open distal gastrectomy versus laparoscopic distal gastrectomy for early gastric cancer: a retrospective study5
Liver microsomal protein content and activity in patients with hepatocellular carcinoma and cirrhosis: implications for the in vivo prediction of individual hepatic clearance5
Combination of the ratio between metastatic and harvested lymph nodes and negative lymph node count as a prognostic indicator in advanced gastric cancer: a retrospective cohort study5
What is the significance of mismatch repair deficiency in stage IV colon cancer?5
Peptidomic changes in human serous colorectal cancer patients5
0.16732215881348